TCG Crossover GP II, LLC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-15 4:18 pm Purchase | 2024-03-06 | 13G | Nektar Therapeutics NKTR | TCG Crossover GP II, LLC | 20,046,350 9.900% | 20,046,350 (New Position) | Filing |